Can DHEA (Dehydroepiandrosterone) and iodine lower blood pressure in an adult patient with a history of hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

DHEA Does Not Lower Blood Pressure and Should Not Be Used for Hypertension Management

DHEA (dehydroepiandrosterone) is not recommended for lowering blood pressure in adults with hypertension, as the evidence shows either no effect or potentially harmful increases in blood pressure. Regarding iodine, it does not directly lower blood pressure, but iodine deficiency can contribute to hypothyroid-related hypertension that resolves with thyroid hormone replacement.

DHEA and Blood Pressure: The Evidence

Human Studies Show No Benefit or Potential Harm

  • Population-based research demonstrates that higher endogenous DHEAS levels are actually associated with higher blood pressure, not lower. In a study of 646 middle-aged adults, DHEAS levels were significantly higher in hypertensive versus normotensive individuals (1.26 vs 1.09 μg/mL, P=0.01), and DHEAS remained independently associated with systolic blood pressure even after adjusting for other adrenal steroids 1.

  • DHEA supplementation failed to prevent ACTH-induced hypertension in controlled studies. When tested at 18 mg/kg per day in rats with ACTH-induced hypertension, DHEA administration for 10 days did not alter blood pressure or metabolic effects 2.

Limited Context Where DHEA May Have Vascular Effects

  • The only evidence suggesting potential benefit is in pulmonary artery hypertension specifically (not systemic hypertension), where DHEA prevented chronic hypoxic pulmonary hypertension in rat models through calcium channel and potassium channel mechanisms 3. This does not translate to treatment of systemic hypertension in humans.

Iodine and Blood Pressure: The Indirect Relationship

Iodine Deficiency Can Cause Hypothyroid-Related Hypertension

  • Hypothyroidism is present in 3.6% of hypertensive patients and causes diastolic hypertension that resolves with thyroid hormone replacement. In a study of 688 consecutive hypertensive patients, 25 had hypothyroidism, and restoration of normal thyroid function lowered diastolic blood pressure below 90 mmHg in 32% of these patients (representing 1.2% of all hypertensive patients) 4.

  • Radioiodine-induced hypothyroidism significantly increases diastolic blood pressure. Among 40 thyrotoxic patients treated with radioiodine, 40% developed diastolic hypertension >90 mmHg, which improved with thyroxine restoration 4.

The Salt Restriction-Iodine Deficiency Connection

  • Dietary salt restriction for hypertension management can lead to iodine deficiency, particularly in women. Women restricting dietary salt had significantly lower urinary iodine concentration (P=0.01) and were 1.79 times more likely to be iodine deficient (P=0.03) compared to women not restricting salt 5.

  • High proportions of adults are already iodine deficient (24.96% of men and 40.42% of women in NHANES 2001-2004), making this interaction clinically relevant 5.

Evidence-Based Hypertension Management

First-Line Interventions Per ACC/AHA Guidelines

The 2017 ACC/AHA guidelines provide clear Class I, Level A recommendations for blood pressure reduction 6, 7, 8:

  • Weight loss in overweight/obese patients
  • DASH diet to facilitate achieving desirable weight
  • Sodium reduction (with attention to maintaining adequate iodine intake through alternative sources)
  • Potassium supplementation (preferably dietary, unless contraindicated by CKD or potassium-sparing drugs)
  • Structured exercise program (150 minutes/week moderate-intensity aerobic activity)
  • Alcohol limitation (≤2 drinks/day for men, ≤1 drink/day for women)

Pharmacological Management

  • For stage 2 hypertension (≥140/90 mmHg), initiate combination therapy with two first-line agents: thiazide diuretics, calcium channel blockers, ACE inhibitors, or ARBs 8.

  • Target blood pressure is <130/80 mmHg for most adults with hypertension 6, 7.

Clinical Recommendations

For patients with hypertension:

  1. Do not recommend DHEA supplementation for blood pressure control
  2. Screen for hypothyroidism (TSH, free T4) if hypertension is difficult to control, particularly if accompanied by fatigue, weight gain, or other hypothyroid symptoms 4
  3. When recommending salt restriction, ensure adequate iodine intake through iodized salt alternatives, dairy products, seafood, or iodine supplementation, especially in women 5
  4. Focus on evidence-based lifestyle modifications and guideline-directed pharmacotherapy 6, 7, 8

References

Research

Dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary hypertension.

Proceedings of the National Academy of Sciences of the United States of America, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.